Effectiveness of Interventional Non-Pharmacological Nursing Pain Management for Preterm Infants at Neonatal Intensive Care Unit
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Pain Management
- Sponsor
- University of Baghdad
- Enrollment
- 105
- Locations
- 1
- Primary Endpoint
- Premature Infant Pain Profile - Revised
- Status
- Completed
- Last Updated
- 2 years ago
Overview
Brief Summary
A randomized controlled trial will be conducted to examine the effect of non-pharmacological nursing pain management strategies in alleviating pain among preterm infants. The study includes a simple random sample of 105 preterm infants with CGA 32- < 37 weeks were randomly assigned into five groups: routine care (n = 21), breast milk (n = 21), oral sucrose (n = 21), KMC (n = 21), nesting position (n = 21). PIPP-R will be used to subjectively assess the pain intensity after heel stick, and salivary cortisol measures will be used to objectively assess the pain intensity in NICU at Children Welfare Teaching Hospital/ Medical City Complex in Baghdad City.
Investigators
Hiba Abdulwahid Dawood
Principal Investigator
University of Baghdad
Eligibility Criteria
Inclusion Criteria
- •Preterm infants whose corrected gestational age from (32 - \<37) weeks of pregnancy,
- •Preterm infants who do not experience any painful procedure for last 24 hours.
- •Preterm infants who do not receive any sedation for last 24 hours, and clinically required heel stick.
Exclusion Criteria
- •Full-term infants whose gestational age (GA) is \>37 weeks
- •Preterm infants who extremely preterm (\< 28 weeks); very preterm (28-\< 32 weeks)
- •Preterm infants who are proven or suspected sepsis, major congenital malformations, heart defect, necrotizing enterocolitis (NEC), and neurodevelopmental disability.
- •Preterm infants who receive respiratory support {Mechanical Ventilation, Continuous Positive Airway Pressure (CPAP), or high-flow support}
- •Preterm infants who are indicated for surgery
- •Preterm infants who are contraindicated to oral sucrose
- •Preterm infants who had a condition that might influence their physiological and responses to pain, e.g., congenital anomalies or severe illnesses requiring treatment with antiepileptics, muscle relaxants, or analgesic drugs.
Outcomes
Primary Outcomes
Premature Infant Pain Profile - Revised
Time Frame: Two months
Premature Infant Pain Profile - Revised measures pain intensity through infant indicators (heart rate, oxygen saturation, brow bulge, eye squeeze). Other indicators in the PIPP-R include gestational age and behavioral state.